Thomas J. Schall's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 9,500 Class A Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Purchase of securities on an exchange or from another person at price $ 3.66 per share. | 27 Jun 2025 | 9,500 | 52,885 | - | 3.7 | 34,788 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 17 Jun 2025 | 40,485 | 43,385 | - | 2.2 | 89,278 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 33,350 | 33,350 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 8,588 | 8,588 | - | - | Stock Option | |
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 22 Mar 2024 | 2,900 | 2,900 | - | 2.5 | 7,385 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 35,000 | 35,000 | - | - | Stock Option |